Filing search / Kineta, Inc. / "Privacy"

8-K

EX-10.1

KANT Kineta, Inc.

29 Feb 24

Kineta Announces Restructuring and Exploration of Strategic Alternatives

7:00am

; claims of wrongful discharge, constructive discharge, emotional distress, defamation, invasion of privacy, fraud, breach of contract, and breach

8-K

EX-10.2

KANT Kineta, Inc.

29 Feb 24

Kineta Announces Restructuring and Exploration of Strategic Alternatives

7:00am

discharge, constructive discharge, emotional distress, defamation, invasion of privacy, fraud, breach of contract, and breach of the covenant of good faith

8-K

EX-10.1

KANT Kineta, Inc.

5 Oct 23

Kineta, Inc. Announces $3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

4:05pm

or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy and security of IT Systems and Data

8-K

EX-10.1

KANT Kineta, Inc.

21 Apr 23

Kineta, Inc. Announces $6 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

5:16pm

of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy and security

8-K

EX-99.5

nwcj7vwu

22 Dec 22

Kineta Completes Reverse Merger with Yumanity Therapeutics

5:02pm

8-K

EX-10.17

x52 zfm5wgd8xtyee

22 Dec 22

Kineta Completes Reverse Merger with Yumanity Therapeutics

5:02pm

8-K

EX-10.15

06c3xp f3234ijsy1pu

22 Dec 22

Kineta Completes Reverse Merger with Yumanity Therapeutics

5:02pm

8-K

EX-10.6

9g089hn6o ituj0lpkbt

22 Dec 22

Kineta Completes Reverse Merger with Yumanity Therapeutics

5:02pm

8-K

EX-99.6

0cv 4qa3eevn5j4

22 Dec 22

Kineta Completes Reverse Merger with Yumanity Therapeutics

5:02pm

8-K

EX-10.16

n7kbe

22 Dec 22

Kineta Completes Reverse Merger with Yumanity Therapeutics

5:02pm

424B3

bhmmbhxww

10 Nov 22

Prospectus supplement

4:21pm